<DOC>
	<DOCNO>NCT02148562</DOCNO>
	<brief_summary>In project proposal , investigator investigate genetic alteration Hepatitis B Virus ( HBV ) strain circulate Belgian patient develop end stage liver disease . Additionally , investigator compare link data set three genetic factor involve immune system response .</brief_summary>
	<brief_title>Assessment Hepatitis B Virus Intra-host Population Host-specific Immune Marker Diversity</brief_title>
	<detailed_description>This project propose identify characterize genetic alteration associate intra-host evolution HBV chronically infection status end-stage liver disease status .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<criteria>Study group : Clinical diagnosis advance liver disease relate chronic Hepatitis B infection ( cirrhosis , hepatocellular carcinoma , .. ) Availability serum sample Control group : Clinical diagnosis liver disease relate chronic Hepatitis B infection preadvanced stage Matched demographic geographic characteristic study group Availability serum sample Liver disease cause hepatotropic virus Patients autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>